An observational study in Advanced Breast Cancer, sponsored by RenJi Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-03.
Sponsored by RenJi Hospital · Observational
To evaluate the efficacy and safety of dalpiciclib in patients with HR-positive/HER2-positive advanced breast cancer.
RenJi Hospital is the lead sponsor of 535 studies on the registry; 244 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Hormone receptor-positive and human epidermal growth factor receptor 2-negative advanced breast cancer
Exclusion Criteria:
dalpiciclib oral day 1-21, every 28 days
Drug: dalpiciclib
dalpiciclib oral day 1-21, every 28 days
Progression-Free Survival
The time from the date of starting dalpiciclib to the date of disease progression as per RECIST version 1.1 or death from any cause, whichever occurs first.
Time frame: From the date of starting dalpiciclib to the date of first documentation of progression or death (up to approximately 1 years)
Adverse events
Adverse events during dalpiciclib treatment will be assessed according to the NCI CTCAE v5.0.
Time frame: From the date of starting dalpiciclib to the end of the treatment (up to approximately 1 year)
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
RenJi Hospital